Source: BBC Health
Researchers from Memorial Sloan-Kettering Hospital, NYC, have found, “Unprecedented” results in the treatment of skin cancer (Melanoma). Melanoma is the deadliest cancer and often metastasizes (spreads) quickly.
A new drug, PLX4032 (A working name only) blocks the BRAF gene, which is widely felt to be responsible for determining the rate of spread of skin cancer. The study of 31 patients with advanced skin cancer resulted in “rapid and dramatic” tumor reduction. Within 2 weeks of the regimen.
A word of caution. Well a few, actually. One, the researchers themselves state that the new treatment is not a cure for skin cancer. Two, drugs in the research stage still take a long time to be approved and marketed in the US. Given that there are few effective treatments for melanoma currently, any promising research is welcome news.
Posted by David Marc Schwadron, Esquire
Become a Fan of the Lewis Law Firm on Facebook